SYNTHESIS OF PYRROLIDINE OXAZOLES AS THROMBOXANE-A(2) ENDOPEROXIDE RECEPTOR ANTAGONISTS

被引:3
作者
HALL, SE
HAN, WC
HARRIS, DN
GOLDENBERG, H
MICHEL, IM
MONSHIZADEGAN, H
WEBB, ML
机构
[1] Bristol-Myers Squibb, Pharmaceutical Research Institute, Princeton, NJ 08543-4000
关键词
D O I
10.1016/S0960-894X(00)80328-5
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
The synthesis and antiplatelet activity of a series of bis-heterocyclic thromboxane A2 receptor antagonists is described. The L-proline analog 9 was the most potent ligand in this class with a K(D) = 7.9+/-0.71 nM in washed human platelets.
引用
收藏
页码:1263 / 1266
页数:4
相关论文
共 11 条
[1]   THROMBOXANE A2 RECEPTOR ANTAGONISTS [J].
HALL, SE .
MEDICINAL RESEARCH REVIEWS, 1991, 11 (05) :503-579
[2]  
HALUSHKA P V, 1989, Drugs of Today, V25, P383
[3]   THROMBOXANES - NEW GROUP OF BIOLOGICALLY-ACTIVE COMPOUNDS DERIVED FROM PROSTAGLANDIN ENDOPEROXIDES [J].
HAMBERG, M ;
SVENSSON, J ;
SAMUELSSON, B .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1975, 72 (08) :2994-2998
[4]   9-ALPHA-HOMO-9,11-EPOXY-5,13-PROSTADIENOIC ACID ANALOGS - SPECIFIC STABLE AGONIST (SQ 26,538) AND ANTAGONIST (SQ 26,536) OF THE HUMAN-PLATELET THROMBOXANE RECEPTOR [J].
HARRIS, DN ;
PHILLIPS, MB ;
MICHEL, IM ;
GOLDENBERG, HJ ;
HEIKES, JE ;
SPRAGUE, PW ;
ANTONACCIO, MJ .
PROSTAGLANDINS, 1981, 22 (02) :295-307
[5]  
HEDBERG A, 1988, J PHARMACOL EXP THER, V245, P786
[6]  
LEFER A M, 1988, Drugs of the Future, V13, P999
[7]   THROMBOXANE RECEPTOR ANTAGONIST BMS-180291 - A NEW PRECLINICAL LEAD [J].
MISRA, RN ;
BROWN, BR ;
SHER, PM ;
PATEL, MM ;
HALL, SE ;
HAN, WC ;
BARRISH, JC ;
FLOYD, DM ;
SPRAGUE, PW ;
MORRISON, RA ;
RIDGEWELL, RE ;
WHITE, RE ;
DIDONATO, GC ;
HARRIS, DN ;
HEDBERG, A ;
SCHUMACHER, WA ;
WEBB, ML ;
OGLETREE, ML .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1992, 2 (01) :73-76
[8]   INTERPHENYLENE 7-OXABICYCLO[2.2.1]HEPTANES - SQ-33961 - A NEW POTENT, LONG-ACTING THROMBOXANE ANTAGONIST [J].
MISRA, RN ;
BROWN, BR ;
SHER, PM ;
PATEL, MM ;
GOLDENBERG, HJ ;
MICHEL, IM ;
HARRIS, DN .
BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 1991, 1 (09) :461-464
[9]  
OGLETREE ML, 1987, FED PROC, V46, P133
[10]  
OGLETREE ML, 1991, CIRCULATION, V84, P79